Page last updated: 2024-10-21

1,10-phenanthroline and Hemochromatosis

1,10-phenanthroline has been researched along with Hemochromatosis in 1 studies

1,10-phenanthroline: RN given refers to parent cpd; inhibits Zn-dependent metalloproteinases

Hemochromatosis: A disorder of iron metabolism characterized by a triad of HEMOSIDEROSIS; LIVER CIRRHOSIS; and DIABETES MELLITUS. It is caused by massive iron deposits in parenchymal cells that may develop after a prolonged increase of iron absorption. (Jablonski's Dictionary of Syndromes & Eponymic Diseases, 2d ed)

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's1 (100.00)2.80

Authors

AuthorsStudies
Groborz, O1
Poláková, L1
Kolouchová, K1
Švec, P1
Loukotová, L1
Miriyala, VM1
Francová, P1
Kučka, J1
Krijt, J1
Páral, P1
Báječný, M1
Heizer, T1
Pohl, R1
Dunlop, D1
Czernek, J1
Šefc, L1
Beneš, J1
Štěpánek, P1
Hobza, P1
Hrubý, M1

Other Studies

1 other study available for 1,10-phenanthroline and Hemochromatosis

ArticleYear
Chelating Polymers for Hereditary Hemochromatosis Treatment.
    Macromolecular bioscience, 2020, Volume: 20, Issue:12

    Topics: Benzene; Gastrointestinal Tract; Hemochromatosis; Humans; Iron; Iron Chelating Agents; Models, Theor

2020